Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 341

1.

Genetic interaction analysis of VEGF-A rs3025039 and VEGFR-2 rs2071559 identifies a genetic profile at higher risk to develop nodular goiter.

Molinaro A, Orlandi P, Niccolai F, Agretti P, De Marco G, Ferrarini E, Di Cosmo C, Vitti P, Piaggi P, Di Desidero T, Bocci G, Tonacchera M.

J Endocrinol Invest. 2019 Aug 2. doi: 10.1007/s40618-019-01092-9. [Epub ahead of print]

PMID:
31376092
2.

Features and outcome of differentiated thyroid carcinoma associated with Graves' disease: results of a large, retrospective, multicenter study.

Premoli P, Tanda ML, Piantanida E, Veronesi G, Gallo D, Masiello E, Rosetti S, Cusini C, Boi F, Bulla J, Rodia R, Mariotti S, Capelli V, Rotondi M, Magri F, Chiovato L, Rocchi R, Campopiano MC, Elisei R, Vitti P, Barbato F, Pilli T, Castagna MG, Pacini F, Bartalena L.

J Endocrinol Invest. 2019 Jul 20. doi: 10.1007/s40618-019-01088-5. [Epub ahead of print]

PMID:
31327128
3.

Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan.

Agate L, Bianchi F, Brozzi F, Santini P, Molinaro E, Bottici V, Viola D, Lorusso L, Vitti P, Elisei R.

Eur Thyroid J. 2019 Apr;8(2):90-95. doi: 10.1159/000494290. Epub 2018 Dec 13.

4.

Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, Mariani S, Lubrano C, Poggiogalle E, Migliaccio S, Donini LM, Basciani S, Cignarelli A, Conte E, Ceccarini G, Bogazzi F, Cimino L, Condorelli RA, La Vignera S, Calogero AE, Gambineri A, Vignozzi L, Prodam F, Aimaretti G, Linsalata G, Buralli S, Monzani F, Aversa A, Vettor R, Santini F, Vitti P, Gnessi L, Pagotto U, Giorgino F, Colao A, Lenzi A; Cardiovascular Endocrinology Club of the Italian Society of Endocrinology.

J Endocrinol Invest. 2019 May 20. doi: 10.1007/s40618-019-01061-2. [Epub ahead of print]

PMID:
31111407
5.

Measurement of urinary free cortisol by LC-MS-MS: adoption of a literature reference range and comparison with our current immunometric method.

Bianchi L, Campi B, Sessa MR, De Marco G, Ferrarini E, Zucchi R, Marcocci C, Vitti P, Manetti L, Saba A, Agretti P.

J Endocrinol Invest. 2019 Apr 22. doi: 10.1007/s40618-019-01050-5. [Epub ahead of print]

PMID:
31012054
6.

DICER1 somatic mutations strongly impair miRNA processing even in benign thyroid lesions.

Poma AM, Condello V, Denaro M, Torregrossa L, Elisei R, Vitti P, Basolo F.

Oncotarget. 2019 Mar 5;10(19):1785-1797. doi: 10.18632/oncotarget.26639. eCollection 2019 Mar 5.

7.

A Case of Oculocutaneous Albinism in a Patient with Hashimoto's Thyroiditis.

de Gennaro G, Vitti P, Marinò M.

Eur Thyroid J. 2019 Jan;8(1):56-58. doi: 10.1159/000493730. Epub 2018 Oct 16.

8.

Comparison between radioiodine therapy and single-session radiofrequency ablation of autonomously functioning thyroid nodules: A retrospective study.

Cervelli R, Mazzeo S, Boni G, Boccuzzi A, Bianchi F, Brozzi F, Santini P, Vitti P, Cioni R, Caramella D.

Clin Endocrinol (Oxf). 2019 Apr;90(4):608-616. doi: 10.1111/cen.13938. Epub 2019 Feb 7.

PMID:
30657603
9.

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment.

Viola D, Agate L, Molinaro E, Bottici V, Lorusso L, Latrofa F, Torregrossa L, Boldrini L, Ramone T, Vitti P, Elisei R.

Front Endocrinol (Lausanne). 2018 Oct 9;9:590. doi: 10.3389/fendo.2018.00590. eCollection 2018.

10.

Thyroid ultrasonography reporting: consensus of Italian Thyroid Association (AIT), Italian Society of Endocrinology (SIE), Italian Society of Ultrasonography in Medicine and Biology (SIUMB) and Ultrasound Chapter of Italian Society of Medical Radiology (SIRM).

Rago T, Cantisani V, Ianni F, Chiovato L, Garberoglio R, Durante C, Frasoldati A, Spiezia S, Farina R, Vallone G, Pontecorvi A, Vitti P.

J Endocrinol Invest. 2018 Dec;41(12):1435-1443. doi: 10.1007/s40618-018-0935-8. Epub 2018 Oct 16.

PMID:
30327945
11.

mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases.

Condello V, Torregrossa L, Sartori C, Denaro M, Poma AM, Piaggi P, Valerio L, Materazzi G, Elisei R, Vitti P, Basolo F.

Mol Cell Endocrinol. 2019 Jan 5;479:93-102. doi: 10.1016/j.mce.2018.09.005. Epub 2018 Sep 24.

PMID:
30261209
12.

Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology.

Rago T, Scutari M, Loiacono V, Tonacchera M, Scuotri G, Romani R, Proietti A, Piaggi P, Elisei R, Basolo F, Latrofa F, Vitti P.

Thyroid. 2018 Oct;28(10):1318-1324. doi: 10.1089/thy.2017.0522.

PMID:
30132418
13.

Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.

Marinò M, Rotondo Dottore G, Ionni I, Lanzolla G, Sabini E, Ricci D, Sframeli A, Mazzi B, Menconi F, Latrofa F, Vitti P, Marcocci C, Chiovato L.

J Endocrinol Invest. 2019 Apr;42(4):471-480. doi: 10.1007/s40618-018-0943-8. Epub 2018 Aug 21.

PMID:
30132285
14.

Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study.

Lanzolla G, Sabini E, Profilo MA, Mazzi B, Sframeli A, Rocchi R, Menconi F, Leo M, Nardi M, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2018 Dec;41(12):1417-1423. doi: 10.1007/s40618-018-0915-z. Epub 2018 Jun 19.

PMID:
29923059
15.

Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without 131I Ablation.

Matrone A, Latrofa F, Torregrossa L, Piaggi P, Gambale C, Faranda A, Ricci D, Agate L, Molinaro E, Basolo F, Vitti P, Elisei R.

Thyroid. 2018 Jul;28(7):871-879. doi: 10.1089/thy.2018.0080.

PMID:
29860933
16.

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience.

Romei C, Tacito A, Molinaro E, Piaggi P, Cappagli V, Pieruzzi L, Matrone A, Viola D, Agate L, Torregrossa L, Ugolini C, Basolo F, De Napoli L, Curcio M, Ciampi R, Materazzi G, Vitti P, Elisei R.

Oncol Lett. 2018 Jun;15(6):9174-9182. doi: 10.3892/ol.2018.8470. Epub 2018 Apr 12.

17.

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.

Pacini F, Basolo F, Bellantone R, Boni G, Cannizzaro MA, De Palma M, Durante C, Elisei R, Fadda G, Frasoldati A, Fugazzola L, Guglielmi R, Lombardi CP, Miccoli P, Papini E, Pellegriti G, Pezzullo L, Pontecorvi A, Salvatori M, Seregni E, Vitti P.

J Endocrinol Invest. 2018 Jul;41(7):849-876. doi: 10.1007/s40618-018-0884-2. Epub 2018 May 4.

PMID:
29729004
18.

Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy.

Rotondo Dottore G, Torregrossa L, Caturegli P, Ionni I, Sframeli A, Sabini E, Menconi F, Piaggi P, Sellari-Franceschini S, Nardi M, Latrofa F, Vitti P, Marcocci C, Basolo F, Marinò M.

JAMA Ophthalmol. 2018 Jun 1;136(6):613-619. doi: 10.1001/jamaophthalmol.2018.0806.

19.

The mutational analysis in the diagnostic work-up of thyroid nodules: the real impact in a center with large experience in thyroid cytopathology.

Macerola E, Rago T, Proietti A, Basolo F, Vitti P.

J Endocrinol Invest. 2019 Feb;42(2):157-166. doi: 10.1007/s40618-018-0895-z. Epub 2018 Apr 27.

PMID:
29704233
20.

mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study.

Mazzeo S, Cervelli R, Elisei R, Tarantini G, Cappelli C, Molinaro E, Galleri D, De Napoli L, Comite C, Cioni R, Vitti P, Caramella D.

J Endocrinol Invest. 2018 Dec;41(12):1389-1399. doi: 10.1007/s40618-018-0886-0. Epub 2018 Apr 23.

PMID:
29687416
21.

Fluoxetine Modulates the Activity of Hypothalamic POMC Neurons via mTOR Signaling.

Barone I, Melani R, Mainardi M, Scabia G, Scali M, Dattilo A, Ceccarini G, Vitti P, Santini F, Maffei L, Pizzorusso T, Maffei M.

Mol Neurobiol. 2018 Dec;55(12):9267-9279. doi: 10.1007/s12035-018-1052-6. Epub 2018 Apr 16.

PMID:
29663284
22.
23.

Occurrence of Graves' Orbitopathy and Graves' Hyperthyroidism after a Trauma to the Eye.

Sabini E, Ionni I, Rocchi R, Vitti P, Marcocci C, Marinò M.

Eur Thyroid J. 2018 Jan;7(1):51-54. doi: 10.1159/000479629. Epub 2017 Aug 22.

24.

Gabriella Morreale de Escobar (1930-2017).

Trimarchi F, Vitti P.

J Endocrinol Invest. 2018 May;41(5):497. doi: 10.1007/s40618-018-0878-0. Epub 2018 Mar 26. No abstract available.

PMID:
29582343
25.

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases.

Romei C, Ciampi R, Casella F, Tacito A, Torregrossa L, Ugolini C, Basolo F, Materazzi G, Vitti P, Elisei R.

Oncotarget. 2018 Jan 4;9(11):9875-9884. doi: 10.18632/oncotarget.23986. eCollection 2018 Feb 9.

26.

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation.

Matrone A, Brancatella A, Marchetti P, Vasile E, Boggi U, Elisei R, Cetani F, Marcocci C, Vitti P, Latrofa F.

Mol Clin Oncol. 2018 Mar;8(3):449-452. doi: 10.3892/mco.2017.1542. Epub 2017 Dec 29.

27.

Rehabilitative orbital decompression for Graves' orbitopathy: results of a randomized clinical trial.

Sellari-Franceschini S, Rocchi R, Marinò M, Bajraktari A, Mazzi B, Fiacchini G, Lepri P, Dallan I, Vitti P, Marcocci C.

J Endocrinol Invest. 2018 Sep;41(9):1037-1042. doi: 10.1007/s40618-018-0847-7. Epub 2018 Feb 15.

PMID:
29450866
28.

Effect of Thyroglobulin Autoantibodies on the Metabolic Clearance of Serum Thyroglobulin.

Latrofa F, Ricci D, Bottai S, Brozzi F, Chiovato L, Piaggi P, Marinò M, Vitti P.

Thyroid. 2018 Mar;28(3):288-294. doi: 10.1089/thy.2017.0052.

PMID:
29439614
29.

TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases.

Insilla AC, Proietti A, Borrelli N, Macerola E, Niccoli C, Vitti P, Miccoli P, Basolo F.

Oncol Lett. 2018 Mar;15(3):2763-2770. doi: 10.3892/ol.2017.7675. Epub 2017 Dec 21.

30.

The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF.

Scabia G, Barone I, Mainardi M, Ceccarini G, Scali M, Buzzigoli E, Dattilo A, Vitti P, Gastaldelli A, Santini F, Pizzorusso T, Maffei L, Maffei M.

Sci Rep. 2018 Jan 29;8(1):1781. doi: 10.1038/s41598-018-19886-x.

31.

High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study.

Sabini E, Mazzi B, Profilo MA, Mautone T, Casini G, Rocchi R, Ionni I, Menconi F, Leo M, Nardi M, Vitti P, Marcocci C, Marinò M.

Thyroid. 2018 Mar;28(3):386-394. doi: 10.1089/thy.2017.0430. Epub 2018 Feb 9.

PMID:
29336220
32.

A six-gene panel to label follicular adenoma, low- and high-risk follicular thyroid carcinoma.

Poma AM, Giannini R, Piaggi P, Ugolini C, Materazzi G, Miccoli P, Vitti P, Basolo F.

Endocr Connect. 2018 Jan;7(1):124-132. doi: 10.1530/EC-17-0261.

33.

Antioxidant effects of β-carotene, but not of retinol and vitamin E, in orbital fibroblasts from patients with Graves' orbitopathy (GO).

Rotondo Dottore G, Ionni I, Menconi F, Casini G, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2018 Jul;41(7):815-820. doi: 10.1007/s40618-017-0809-5. Epub 2017 Dec 18.

PMID:
29256181
34.

Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question.

Sabini E, Leo M, Mazzi B, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marinò M.

Eur Thyroid J. 2017 Sep;6(5):263-270. doi: 10.1159/000477803. Epub 2017 Jun 26.

35.

Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms.

Proietti A, Sartori C, Macerola E, Borrelli N, Materazzi G, Vitti P, Basolo F.

Virchows Arch. 2017 Dec;471(6):769-773. doi: 10.1007/s00428-017-2236-6. Epub 2017 Oct 3.

PMID:
28975450
36.

Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients.

Leo M, Sabini E, Ionni I, Sframeli A, Mazzi B, Menconi F, Molinaro E, Bianchi F, Brozzi F, Santini P, Elisei R, Nardi M, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2018 Mar;41(3):357-361. doi: 10.1007/s40618-017-0754-3. Epub 2017 Aug 30.

PMID:
28856610
37.

Differences in miRNA expression profiles between wild-type and mutated NIFTPs.

Denaro M, Ugolini C, Poma AM, Borrelli N, Materazzi G, Piaggi P, Chiarugi M, Miccoli P, Vitti P, Basolo F.

Endocr Relat Cancer. 2017 Oct;24(10):543-553. doi: 10.1530/ERC-17-0167.

PMID:
28830935
38.

Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype.

Berger S, Ceccarini G, Scabia G, Barone I, Pelosini C, Ferrari F, Magno S, Dattilo A, Chiovato L, Vitti P, Santini F, Maffei M.

Int J Obes (Lond). 2017 Nov;41(11):1676-1684. doi: 10.1038/ijo.2017.163. Epub 2017 Jul 10.

PMID:
28761130
39.

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Molinaro E, Romei C, Biagini A, Sabini E, Agate L, Mazzeo S, Materazzi G, Sellari-Franceschini S, Ribechini A, Torregrossa L, Basolo F, Vitti P, Elisei R.

Nat Rev Endocrinol. 2017 Nov;13(11):644-660. doi: 10.1038/nrendo.2017.76. Epub 2017 Jul 14. Review.

PMID:
28707679
40.

Identification of Two Distinct Molecular Subtypes of Non-Invasive Follicular Neoplasm with Papillary-Like Nuclear Features by Digital RNA Counting.

Giannini R, Ugolini C, Poma AM, Urpì M, Niccoli C, Elisei R, Chiarugi M, Vitti P, Miccoli P, Basolo F.

Thyroid. 2017 Oct;27(10):1267-1276. doi: 10.1089/thy.2016.0605. Epub 2017 Sep 5.

PMID:
28679352
41.

Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?

Rotondo Dottore G, Ionni I, Menconi F, Casini G, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2018 Feb;41(2):193-201. doi: 10.1007/s40618-017-0718-7. Epub 2017 Jun 27.

PMID:
28656526
42.

Selenium in the Treatment of Thyroid Diseases.

Marinò M, Marcocci C, Vitti P, Chiovato L, Bartalena L.

Eur Thyroid J. 2017 Apr;6(2):113-114. doi: 10.1159/000456660. Epub 2017 Mar 1. No abstract available.

43.

Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin.

Botta R, Lisi S, Rotondo Dottore G, Vitti P, Marinò M.

J Endocrinol Invest. 2017 Sep;40(9):991-997. doi: 10.1007/s40618-017-0668-0. Epub 2017 Apr 5.

PMID:
28382504
44.

Erratum to: Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves' orbitopathy.

Rotondo Dottore G, Chiarini R, De Gregorio M, Leo M, Casini G, Cestari L, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

Endocrine. 2017 Nov;58(2):390. doi: 10.1007/s12020-017-1255-z. No abstract available.

PMID:
28190240
45.

BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report.

Macerola E, Torregrossa L, Ugolini C, Bakkar S, Vitti P, Fadda G, Basolo F.

Int J Surg Pathol. 2017 Jun;25(4):348-351. doi: 10.1177/1066896916688083. Epub 2017 Jan 23.

PMID:
28112041
46.

Selenium rescues orbital fibroblasts from cell death induced by hydrogen peroxide: another molecular basis for the effects of selenium in graves' orbitopathy.

Rotondo Dottore G, Chiarini R, De Gregorio M, Leo M, Casini G, Cestari L, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

Endocrine. 2017 Nov;58(2):386-389. doi: 10.1007/s12020-016-1226-9. Epub 2017 Jan 17. No abstract available. Erratum in: Endocrine. 2017 Feb 11;:.

PMID:
28097622
47.

The way forward in Italy for iodine.

Olivieri A, DI Cosmo C, DE Angelis S, DA Cas R, Stacchini P, Pastorelli A, Vitti P; Regional Observatories for Goiter Prevention.

Minerva Med. 2017 Apr;108(2):159-168. doi: 10.23736/S0026-4806.17.04877-7. Epub 2017 Jan 12. Review.

PMID:
28079352
48.

Iodine nutritional status and thyroid effects of exposure to ethylenebisdithiocarbamates.

Medda E, Santini F, De Angelis S, Franzellin F, Fiumalbi C, Perico A, Gilardi E, Mechi MT, Marsili A, Citroni A, Leandri A, Mantovani A, Vitti P, Olivieri A.

Environ Res. 2017 Apr;154:152-159. doi: 10.1016/j.envres.2016.12.019. Epub 2017 Jan 7.

PMID:
28073049
49.

Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.

Leo M, Maggi F, Dottore GR, Casini G, Mazzetti P, Pistello M, Sellari-Franceschini S, Nardi M, Vitti P, Marcocci C, Marinò M.

J Endocrinol Invest. 2017 May;40(5):499-503. doi: 10.1007/s40618-016-0587-5. Epub 2016 Dec 16.

PMID:
27987077
50.

Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation.

Matrone A, Gambale C, Piaggi P, Viola D, Giani C, Agate L, Bottici V, Bianchi F, Materazzi G, Vitti P, Molinaro E, Elisei R.

J Clin Endocrinol Metab. 2017 Mar 1;102(3):893-902. doi: 10.1210/jc.2016-2860.

PMID:
27929713

Supplemental Content

Support Center